Affiliation: University of Ilorin

Associate Professor Dr. Olubunmi Atolani is a natural products/medical chemist whose research focuses on investigating and characterizing the anti-cancer, cytotoxic, and antioxidant properties of traditional medicine. He uses chemoinformatic tools for drug discovery in cancer, diabetes, malaria, and infection conditions. He has authored over one hundred peer-reviewed journal articles (Scopus-indexed majority), books, numerous book chapters, and delivered keynote addresses at conferences. He is an experienced reviewer for several reputable journals, including Wiley, Elsevier, Taylor & Francis, and others. He was the managing editor of Annals of Science and Technology, published by De Gruyter/SCIENDO in Europe, and an editorial board member of various scientific journals. He is a principal investigator (PI) in various research groups and has been awarded numerous international, national, and institutional competitive scientific research grants and awards, such as those from the Deutsche Forschungsgemeinschaft-Germany, UNESCO, TWAS-DFG, TWAS-ICCBS, TWAS-CIIT, Seeding Labs, EACR, TETFund, and Raw Material Grants. He is a member of several committees and boards within and outside the university system. He is a member of reputable national and international professional and academic bodies such as the European Association of Cancer Researchers (EACR), the Royal Society of Chemistry (RSC), the American Chemical Society (ACS), the Institute of Chartered Chemists of Nigeria (ICCON), the Chemical Society of Nigeria (CSN), the Nigerian Young Academy (NYA), etc. He is currently a faculty member at the University of Ilorin, Ilorin, Nigeria, where he teaches and supervises both undergraduate and postgraduate students.